185 related articles for article (PubMed ID: 37119181)
21. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis Codes and Case Definitions for Neonatal Abstinence Syndrome.
Elmore AL; Tanner JP; Lowry J; Lake-Burger H; Kirby RS; Hudak ML; Sappenfield WM; Salemi JL
Pediatrics; 2020 Sep; 146(3):. PubMed ID: 32848030
[TBL] [Abstract][Full Text] [Related]
23. Diagnoses during the First Three Years of Life for Children with Prenatal Opioid Exposure and Neonatal Abstinence Syndrome Using a Large Maternal Infant Data Hub.
Arter S; Lambert J; Brokman A; Fall N
J Pediatr Nurs; 2021; 61():34-39. PubMed ID: 33743318
[TBL] [Abstract][Full Text] [Related]
24. How Might Maternal Poverty Impact the Course of Neonatal Opioid Withdrawal Syndrome?
Wachman EM
J Addict Med; 2020; 14(2):93-94. PubMed ID: 31149916
[TBL] [Abstract][Full Text] [Related]
25. Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis.
Weller AE; Crist RC; Reiner BC; Doyle GA; Berrettini WH
Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32229609
[TBL] [Abstract][Full Text] [Related]
26. Trajectories of Prescription Opioid Utilization During Pregnancy Among Prepregnancy Chronic Users and Risk of Neonatal Opioid Withdrawal Syndrome.
Straub L; Huybrechts KF; Hernández-Díaz S; Zhu Y; Vine S; Desai RJ; Gray KJ; Bateman BT
Am J Epidemiol; 2022 Jan; 191(1):208-219. PubMed ID: 34643225
[TBL] [Abstract][Full Text] [Related]
27. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence.
Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P
Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797
[TBL] [Abstract][Full Text] [Related]
28. The Time is NOW: Filling the Gaps in Treatment of Opioid-Exposed Infants: A Prospective, Pragmatic, Randomized Control Drug Trial.
Czynski AJ; Laptook AR
R I Med J (2013); 2021 Apr; 104(3):17-21. PubMed ID: 33789403
[TBL] [Abstract][Full Text] [Related]
29. Infant Mortality Associated With Prenatal Opioid Exposure.
Leyenaar JK; Schaefer AP; Wasserman JR; Moen EL; O'Malley AJ; Goodman DC
JAMA Pediatr; 2021 Jul; 175(7):706-714. PubMed ID: 33843963
[TBL] [Abstract][Full Text] [Related]
30. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.
Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A
Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611
[TBL] [Abstract][Full Text] [Related]
31. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
[No Abstract] [Full Text] [Related]
32. Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome.
Radhakrishna U; Vishweswaraiah S; Uppala LV; Szymanska M; Macknis J; Kumar S; Saleem-Rasheed F; Aydas B; Forray A; Muvvala SB; Mishra NK; Guda C; Carey DJ; Metpally RP; Crist RC; Berrettini WH; Bahado-Singh RO
Genomics; 2021 May; 113(3):1127-1135. PubMed ID: 33711455
[TBL] [Abstract][Full Text] [Related]
33. Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome.
Kuzniewicz MW; Campbell CI; Li S; Walsh EM; Croen LA; Comer SD; Pimentel SD; Hedderson M; Sun LS
J Perinatol; 2023 Mar; 43(3):293-299. PubMed ID: 36131095
[TBL] [Abstract][Full Text] [Related]
34. Transitioning Care Approach for Neonatal Opioid Withdrawal Syndrome and Neonatal Abstinence Syndrome.
Perez C
Crit Care Nurs Clin North Am; 2024 Jun; 36(2):223-233. PubMed ID: 38705690
[TBL] [Abstract][Full Text] [Related]
35. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations.
Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M
Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504
[TBL] [Abstract][Full Text] [Related]
36. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
37. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018.
Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB
Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554
[No Abstract] [Full Text] [Related]
38. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
Gersch H; Shah D; Chroust A; Bailey B
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
[TBL] [Abstract][Full Text] [Related]
39. Understanding barriers to timely identification of infants at risk of neonatal opiate withdrawal syndrome.
Howell MP; Smith AM; Lindsay EB; Drury SS
J Matern Fetal Neonatal Med; 2021 Apr; 34(7):1161-1166. PubMed ID: 31195865
[TBL] [Abstract][Full Text] [Related]
40. Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice.
Borrelli KN; Wingfield KK; Yao EJ; Zamorano CA; Sena KD; Beierle JA; Roos MA; Zhang H; Wachman EM; Bryant CD
Neuropharmacology; 2023 Dec; 240():109732. PubMed ID: 37774943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
